ArticleFrontiers in ophthalmology2026

Reassessing high-dose ranibizumab in the era of durable anti-VEGF therapy.

Cheng-Kuo Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.